Schedule 13D ownership disclosure
Health Catalyst Inc
Common Stock, par value $0.001 per share · CUSIP: 42225T107
Event date: 2026-01-15
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Whetstone Capital Advisors, LLCReported CIK 0001607278
Shares: 5,265,377 · Class: 7.4%
- David Atterbury
Shares: 5,265,377 · Class: 7.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-017290
- Form type
- SCHEDULE 13D
- Filer
- Health Catalyst, Inc.
- CIK
- CIK 1636422
- Filed
- Jan 21, 2026
- Reporting period
- Jan 15, 2026
- Description
- Schedule 13D beneficial ownership